![Maged Shenouda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maged Shenouda
Financieel Directeur/CFO bij
RELMADA THERAPEUTICS, INC.
Vermogen: 4 M $ op 31-07-2026
Profiel
Mr. Maged S.
Shenouda is a Chief Financial Officer at Relmada Therapeutics, Inc. Mr. Shenouda was previously employed as a Chief Financial & Accounting Officer by Entero Therapeutics, Inc., a Senior VP, Head-Business Development & Licensing by Travere Therapeutics, Inc., a Managing Director by Blueprint Life Science Group, a Managing Director by Stifel, Nicolaus & Co., Inc., an Analyst by UBS Securities LLC, an Analyst by JPMorgan Securities, Inc., a Principal by Abbott Laboratories, an Analyst by Bear, Stearns & Co., Inc., a Management Consultant by Pricewaterhouse & Co., and an Analyst by Salomon Smith Barney.
He also served on the board at Protea Biosciences Group, Inc. and Protea Biosciences, Inc. He received his undergraduate degree from St. John's University and an MBA from Rutgers Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-03-2026 | 800.000 ( 0,76% ) | 4 M $ | 31-07-2026 |
Actieve functies van Maged Shenouda
| Bedrijven | Functie | Begin |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Financieel Directeur/CFO | 09-01-2020 |
Eerdere bekende functies van Maged Shenouda
| Bedrijven | Functie | Einde |
|---|---|---|
| GRIDAI TECHNOLOGIES CORP. | Financieel Directeur/CFO | 01-12-2019 |
| PROTEA BIOSCIENCES GROUP, INC | Directeur/Bestuurslid | 09-06-2017 |
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2014 |
Blueprint Life Science Group
 Blueprint Life Science Group Miscellaneous Commercial ServicesCommercial Services Blueprint Life Science Group is a healthcare-dedicated corporate advisory and investor relations firm. The company offers a full suite of investor relations and proprietary strategic advisory services to their clients. Founded in 2006, the company works behind the scenes and at the forefront of daily IR operations to enhance management's ability to make strategic decisions and produce results. The company has a diversified team with backgrounds in portfolio management, sellside research, equity capital markets, design and media, and investor communications. Blueprint's investor relations platform is designed to bolster clients' overall presence in the life science community while providing a robust flow of information and ideas. The firm also has a seasoned Board of Advisors that assists in validating strategies and facilitating outcomes while serving as an additional resource for clients. The company is based in San Francisco, CA. | Corporate Officer/Principal | 01-09-2013 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-01-2011 |
Opleiding van Maged Shenouda
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
97
Eerstegraads connecties
15
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 15 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Provides investment banking, securities trading and brokerage Services | Finance |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Protea Biosciences, Inc.
 Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Develops technology for micro fluidic protein separation and detection | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pricewaterhouse & Co.
 Pricewaterhouse & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salomon Smith Barney
 Salomon Smith Barney Investment Banks/BrokersFinance Provides brokerage services | Finance |
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides innovative bioanalytical solutions | Commercial Services |
Blueprint Life Science Group
Blueprint Life Science Group Miscellaneous Commercial ServicesCommercial Services Blueprint Life Science Group is a healthcare-dedicated corporate advisory and investor relations firm. The company offers a full suite of investor relations and proprietary strategic advisory services to their clients. Founded in 2006, the company works behind the scenes and at the forefront of daily IR operations to enhance management's ability to make strategic decisions and produce results. The company has a diversified team with backgrounds in portfolio management, sellside research, equity capital markets, design and media, and investor communications. Blueprint's investor relations platform is designed to bolster clients' overall presence in the life science community while providing a robust flow of information and ideas. The firm also has a seasoned Board of Advisors that assists in validating strategies and facilitating outcomes while serving as an additional resource for clients. The company is based in San Francisco, CA. | Commercial Services |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entero Therapeutics, Inc.
 Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
